Curacle is a Korean biopharmaceutical company leading the research and development of new drugs in the field of intractable vascular diseases.
Curacle's research focuses on the development of endothelial dysfunction blockers utilizing the SOLVADYS® platform.
We are conducting research and development in various therapeutic areas with high potential for business and clinical differentiation, including CU06, a retinal vascular disease treatment, and aiming to achieve the goal of being the first Korean company to launch a blockbuster drug through development of a First-in-Class drug.
Company Details
- Employees
- 7
- Founded
- 2016
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.curacle.com/
Curacle Questions
Curacle's website is http://www.curacle.com/
Curacle's LinkedIn profile is https://www.linkedin.com/company/curacle
Curacle has
7 employees.
View email and phone details for 7
employees at Curacle.
Curacle's industry is
Biotechnology Research
Curacle's top competitors are
The Bio (더바이오),
Ace Vision Group,
Virocure,
Ibex Biosciences, Inc.,
Galimedix Therapeutics, Inc.,
Anaptysbio,
Acs Division Of Medicinal Chemistry,
Uppthera, Inc.,
Théa Open Innovation,
Brainvisioncenter.
Curacle's categories are Biotechnology Research
Curacle's founding year is 2016
